EPIDYOLEX

GW Research Limited

Application Filed: 2018-07-18

Trademark Application Details

Status

641

Live/Pending

NON-FINAL ACTION - MAILED

Research	OneLook Acronym Finder
Serial Number	79240362
Registration Number	6060891
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Law Office Assigned	L80
Employee Name	LOOK, JEFFREY J

Timeline

2018-07-18	Application Filed
2019-06-26	Location: TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
2019-07-19	Status: Live/Pending
2019-08-09	Transaction Date
2020-05-26	Trademark Registered

Trademark Applicants & Owners

Owner:	GW Research Limited
Entity Statement	Limited company
Address	Sovereign House, Vision Park, Chivers Way, Histon; Cambridge CB24 9BZ GB
Legal Entity Type
Legal Entity State	GB

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Gill Jennings & Every LLP
The Broadgate Tower,
20 Primrose Street
London EC2A 2ES
UNITED KINGDOM

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	31
U.S. Codes:	001,046

Type Code	Type
GS0051	Pharmaceutical and veterinary preparations and substances; pharmaceutical preparations and substances for the treatment of epilepsy; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions; pure extracts of medicinal plants and herbs; foodstuffs for medicinal purposes; herb teas for medicinal purposes; all of the aforesaid for the treatment of neurological diseases and conditions
GS0051	Pharmaceutical and veterinary preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome

Type Code

Type

GS0051

Pharmaceutical and veterinary preparations and substances; pharmaceutical preparations and substances for the treatment of epilepsy; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions; pure extracts of medicinal plants and herbs; foodstuffs for medicinal purposes; herb teas for medicinal purposes; all of the aforesaid for the treatment of neurological diseases and conditions

GS0051

Pharmaceutical and veterinary preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome

Trademark Filing History

Description	Date	Event Coding
SN ASSIGNED FOR SECT 66A APPL FROM IB	2018-09-06	1 REPR M:
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2018-09-13	2 NWOS I:Incoming Correspondence
APPLICATION FILING RECEIPT MAILED	2018-09-18	3 MAFR O:Outgoing Correspondence
ASSIGNED TO EXAMINER	2018-11-05	4 DOCK D:Assigned to Examiner
ASSIGNED TO EXAMINER	2018-11-07	5 DOCK D:Assigned to Examiner
ASSIGNED TO EXAMINER	2019-06-24	6 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2019-06-26	7 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	2019-06-27	8 RFCR E:E-Mail
REFUSAL PROCESSED BY MPU	2019-07-19	9 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	2019-07-19	10 RFCS P:
REFUSAL PROCESSED BY IB	2019-08-09	11 RFNT P:
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2020-01-17	12 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2020-01-17	13 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2020-01-17	14 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2020-01-31	15 CNSA O:Outgoing Correspondence
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB	2020-02-12	16 OPNR P:
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	2020-02-12	17 OPNS P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2020-02-19	18 NONP E:E-Mail
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB	2020-02-19	19 OP2R P:
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	2020-02-19	20 OPNS P:
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB	2020-02-28	21 OPNX P:
NOTIFICATION PROCESSED BY IB	2020-03-06	22 GPNX P:
PUBLISHED FOR OPPOSITION	2020-03-10	23 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2020-03-10	24 NPUB E:E-Mail
REGISTERED-PRINCIPAL REGISTER	2020-05-26	25 R.PR A:Allowance for Publication
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	2020-08-26	26 FICR P:
FINAL DISPOSITION PROCESSED	2020-09-25	27 FIMP P:
FINAL DISPOSITION NOTICE SENT TO IB	2020-09-25	28 FICS P:
FINAL DECISION TRANSACTION PROCESSED BY IB	2020-10-17	29 FINO P:
TEAS CHANGE OF OWNER ADDRESS RECEIVED	2021-09-15	30 COAR I:Incoming Correspondence
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	2021-09-15	31 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	2021-09-15	32 ARAA I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2021-09-15	33 TCCA I:Incoming Correspondence
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED	2021-09-15	34 CHAN I:Incoming Correspondence
NEW REPRESENTATIVE AT IB RECEIVED	2021-11-20	35 NREP P:

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
EPIDYOLEX 79330763 not registered Live/Pending	GW Research Ltd 2021-06-23
EPIDYOLEX 79240362 not registered Live/Pending	GW Research Limited 2018-07-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.